Viatris Readies Landmark Botox Biosimilar, Clinical Trial Coming In H1 2024

Key IND Filing With USFDA Planned For Year-End; Launch In 2026 Slated

 
• By Dean Rudge
  
Botox
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products